Wits Vida Research Unit
Research, 1 American BLVD, Soweto, Ohio, 44145, United States, 201-500 Employees
Phone Number: +14*********
Who is WITS VIDA RESEARCH UNIT
The Vaccines and Infectious Diseases Analytics (VIDA) Research Unit of the University of the Witwatersrand, formerly the Respiratory and Meningeal Pathogens Research Unit (RMPRU), has ove...
Read More
- Headquarters: 1 American BLVD, Soweto, Ohio, 44145, United States
- Date Founded: 1997
- Employees: 201-500
- Revenue: $1 Billion and Over
- Active Tech Stack: See technologies
Does something look wrong? Fix it. | View contact records from WITS VIDA RESEARCH UNIT
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Wits VIDA Research Unit
Answer: Wits VIDA Research Unit's headquarters are located at 1 American BLVD, Soweto, Ohio, 44145, United States
Answer: Wits VIDA Research Unit's phone number is +14*********
Answer: Wits VIDA Research Unit's official website is https://wits-vida.org
Answer: Wits VIDA Research Unit's revenue is $1 Billion and Over
Answer: Wits VIDA Research Unit's SIC: 2771
Answer: Wits VIDA Research Unit's NAICS: 424990
Answer: Wits VIDA Research Unit has 201-500 employees
Answer: Wits VIDA Research Unit is in Research
Answer: Wits VIDA Research Unit contact info: Phone number: +14********* Website: https://wits-vida.org
Answer: The Vaccines and Infectious Diseases Analytics (VIDA) Research Unit of the University of the Witwatersrand, formerly the Respiratory and Meningeal Pathogens Research Unit (RMPRU), has over the past 24 years established itself as an internationally recognised African-led research unit in the field of epidemiology of vaccine preventable diseases, and clinical development of life-saving vaccines. Current focus areas include next generation vaccines against rotavirus and TB, as well as development of novel vaccines targeted at pregnant women to protect their young infants against the leading causes of sepsis (Group B Streptococcus vaccine) and pneumonia (Respiratory Syncytial Virus vaccine) during early infancy. Furthermore, VIDA is one of seven participating units in the multi-country Child Health and Mortality Prevention Surveillance (CHAMPS) programme, which aims at providing refined estimates as to the causes of stillbirths and under-5 childhood deaths in low-middle income countries (LMICs). In 2020, VIDA embarked on leading the first two COVID-19 vaccine studies being undertaken on the African continent, and has undertaken multiple epidemiological and immunology studies on COVID-19 in health-care workers, adults and pregnant women. The translational research undertaken at VIDA continues to inform local and global policy recommendations on the use of life-saving vaccines in the public immunisation programmes of low-middle income countries.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month